{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Rule\" and posted_year = 2010 sorted by posted_date descending", "rows": [["FDA-2010-N-0002-0088", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Deslorelin", "Rule", "NFR-Notice of Final Rule", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T15:43:43Z", "2010-32554", 0, 0, "0900006480bc0c09"], ["FDA-2010-N-0002-0087", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsor's Address", "Rule", "NFR-Notice of Final Rule", "2010-12-21T05:00:00Z", 2010, 12, "2010-12-21T05:00:00Z", null, "2010-12-21T14:31:22Z", "2010-31952", 0, 0, "0900006480bbcc1e"], ["FDA-2010-N-0002-0085", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Mupirocin", "Rule", "NFR-Notice of Final Rule", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", null, "2010-12-20T14:51:05Z", "2010-31870", 0, 0, "0900006480bba052"], ["FDA-2000-N-0011-0006", "FDA", "FDA-2000-N-0011", "Uniform Compliance Date for Food Labeling Regulations", "Rule", "NFR-Notice of Final Rule", "2010-12-15T05:00:00Z", 2010, 12, "2010-12-15T05:00:00Z", "2011-02-15T04:59:59Z", "2010-12-16T16:05:14Z", "2010-31382", 0, 0, "0900006480bb6fad"], ["FDA-2010-N-0002-0081", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Tylosin", "Rule", "NFR-Notice of Final Rule", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", null, "2010-12-08T15:43:21Z", "2010-30814", 0, 0, "0900006480bb1e23"], ["FDA-2010-N-0002-0083", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Flunixin", "Rule", "NFR-Notice of Final Rule", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", null, "2010-12-08T16:18:02Z", "2010-30769", 0, 0, "0900006480bb1ea7"], ["FDA-2010-N-0560-0002", "FDA", "FDA-2010-N-0560", "Amendments to General Regulations of Food and Drug Administration", "Rule", "NFR-Notice of Final Rule", "2010-11-30T05:00:00Z", 2010, 11, "2010-11-30T05:00:00Z", "2011-02-15T04:59:59Z", "2011-06-11T16:28:39Z", "2010-30039", 0, 0, "0900006480ba9048"], ["FDA-2010-N-0002-0080", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor's Name and Address", "Rule", "NFR-Notice of Final Rule", "2010-11-26T05:00:00Z", 2010, 11, "2010-11-26T05:00:00Z", null, "2024-11-07T22:30:37Z", "2010-29693", 1, 0, "0900006480ba43cf"], ["FDA-2010-N-0002-0079", "FDA", "FDA-2010-N-0002", "Intramammary Dosage Form New Animal Drugs: Cloxacillin Benzathine", "Rule", "NFR-Notice of Final Rule", "2010-11-22T05:00:00Z", 2010, 11, "2010-11-22T05:00:00Z", null, "2024-11-07T22:25:26Z", "2010-29326", 1, 0, "0900006480ba0922"], ["FDA-2010-N-0513-0001", "FDA", "FDA-2010-N-0513", "Medical Devices; General and Plastic Surgery Devices: Classification of Non-Powered Suction Apparatus Device Intended for NegativePressure Wound Therapy", "Rule", "NFR-Notice of Final Rule", "2010-11-17T05:00:00Z", 2010, 11, null, null, "2010-11-17T21:39:49Z", "2010-28873", 0, 0, "0900006480b954fb"], ["FDA-2010-N-0534-0002", "FDA", "FDA-2010-N-0534", "New Animal Drugs for Minor Use and Minor Species", "Rule", "NFR-Notice of Final Rule", "2010-11-15T05:00:00Z", 2010, 11, "2010-11-15T05:00:00Z", "2011-02-01T04:59:59Z", "2024-11-12T04:55:47Z", "2010-28550", 1, 0, "0900006480b88cdc"], ["FDA-2010-N-0002-0078", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsor: Sulfadiazine and Pyrimethamine Suspension", "Rule", "NFR-Notice of Final Rule", "2010-11-15T05:00:00Z", 2010, 11, null, null, "2010-11-15T17:45:37Z", "2010-28549", 0, 0, "0900006480b88cdb"], ["FDA-2010-N-0002-0077", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsors Name", "Rule", "CEP-Certificate Extending Patent Term", "2010-11-10T05:00:00Z", 2010, 11, "2010-11-10T05:00:00Z", null, "2010-11-10T15:57:56Z", "2010-28307", 0, 0, "0900006480b86258"], ["FDA-2010-N-0512-0001", "FDA", "FDA-2010-N-0512", "Medical Devices; General and Plastic Surgery Devices: Classification of Tissue Adhesive With Adjunct Wound Closure Device Intended for Topical Approximation of Skin", "Rule", "CEP-Certificate Extending Patent Term", "2010-11-10T05:00:00Z", 2010, 11, "2010-11-10T05:00:00Z", null, "2012-09-27T02:01:12Z", "2010-28356", 0, 0, "0900006480b861ad"], ["FDA-2008-N-0273-0018", "FDA", "FDA-2008-N-0273", "Medical Devices: Radiology Devices; Reclassification of Full-Field Digital Mammography System", "Rule", "NFR-Notice of Final Rule", "2010-11-05T04:00:00Z", 2010, 11, null, null, "2010-11-05T17:36:15Z", "2010-28007", 0, 0, "0900006480b8254d"], ["FDA-2010-N-0002-0075", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Domperidone", "Rule", "NFR-Notice of Final Rule", "2010-11-01T04:00:00Z", 2010, 11, null, null, "2010-11-01T15:15:29Z", "2010-27524", 0, 0, "0900006480b7c883"], ["FDA-2010-N-0002-0074", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor; Monensin Blocks", "Rule", "NFR-Notice of Final Rule", "2010-10-28T04:00:00Z", 2010, 10, null, null, "2010-10-28T15:36:14Z", "2010-27287", 0, 0, "0900006480b79676"], ["FDA-2010-N-0002-0073", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran", "Rule", "NFR-Notice of Final Rule", "2010-10-26T04:00:00Z", 2010, 10, null, null, "2010-10-26T14:48:15Z", "2010-27011", 0, 0, "0900006480b7753a"], ["FDA-2010-N-0002-0071", "FDA", "FDA-2010-N-0002", "Certain Other Dosage Form New Animal Drugs: Progesterone Intravaginal Inserts", "Rule", "NFR-Notice of Final Rule", "2010-10-14T04:00:00Z", 2010, 10, null, null, "2010-10-14T17:22:27Z", "2010-25893", 0, 0, "0900006480b6eed0"], ["FDA-1981-N-0299-0007", "FDA", "FDA-1981-N-0299", "Order to Revise Existing Standards and Establishment of New Identity Standards; Final Rule", "Rule", "NFR-Notice of Final Rule", "2010-10-12T04:00:00Z", 2010, 10, "2010-10-12T04:00:00Z", "1973-11-10T04:59:59Z", "2010-10-12T22:36:48Z", null, 0, 0, "09000064805b14b7"], ["FDA-2010-N-0002-0069", "FDA", "FDA-2010-N-0002", "Implantation and Injectable Dosage Form New Animal Drugs: Ceftiofur Crystalline Free Acid; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-10-12T04:00:00Z", 2010, 10, "2010-10-12T04:00:00Z", null, "2010-10-12T15:25:22Z", "2010-25527", 0, 0, "0900006480b6c491"], ["FDA-1982-F-0155-0002", "FDA", "FDA-1982-F-0155", "Direct Food Additives: Food Additives Permitted For Direct Addition To Food For Human Consumption; Dimethyl Dicarbonate", "Rule", "NFR-Notice of Final Rule", "2010-10-07T04:00:00Z", 2010, 10, "2010-10-07T04:00:00Z", "1988-11-22T04:59:59Z", "2010-10-07T15:25:08Z", null, 0, 0, "090000648050f626"], ["FDA-2010-N-0002-0066", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine", "Rule", "NFR-Notice of Final Rule", "2010-09-30T04:00:00Z", 2010, 9, "2010-09-30T04:00:00Z", null, "2010-09-30T15:28:17Z", "2010-24494", 0, 0, "0900006480b64109"], ["FDA-2010-N-0002-0068", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds; Melengestrol", "Rule", "NFR-Notice of Final Rule", "2010-09-30T04:00:00Z", 2010, 9, "2010-09-30T04:00:00Z", null, "2010-09-30T15:42:59Z", "2010-24480", 0, 0, "0900006480b64158"], ["FDA-2000-N-0108-0071", "FDA", "FDA-2000-N-0108", "Final Rule re Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products: Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans", "Rule", "Final Rule", "2010-09-29T04:00:00Z", 2010, 9, "2010-09-29T04:00:00Z", null, "2016-02-24T19:19:31Z", "2010-24296", 0, 0, "0900006480b63055"], ["FDA-2010-N-0002-0064", "FDA", "FDA-2010-N-0002", "Implantation and Injectable Dosage Form New Animal Drugs: Firocoxib", "Rule", "NFR-Notice of Final Rule", "2010-09-28T04:00:00Z", 2010, 9, "2010-09-28T04:00:00Z", null, "2010-09-28T14:58:35Z", "2010-24254", 0, 0, "0900006480b62263"], ["FDA-2009-N-0344-0003", "FDA", "FDA-2009-N-0344", "Microbiology Devices: Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays; Confirmation of Effective Date", "Rule", "NCD-Notice of Confirmation of Effective Date", "2010-09-28T04:00:00Z", 2010, 9, "2010-09-28T04:00:00Z", null, "2010-09-28T14:23:52Z", "2010-23638", 0, 0, "0900006480b62224"], ["FDA-2010-N-0002-0063", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Chloramphenicol; Lincomycin;Pyrantel Tartrate; and Tylosin Phosphate and Sulfamethazine", "Rule", "NFR-Notice of Final Rule", "2010-09-14T04:00:00Z", 2010, 9, null, null, "2010-09-14T15:22:40Z", "2010-22808", 0, 0, "0900006480b4ea9e"], ["FDA-1997-N-0011-0047", "FDA", "FDA-1997-N-0011", "Notice of Final Rule re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing", "Rule", "Final Rule", "2010-09-10T04:00:00Z", 2010, 9, "2010-09-10T04:00:00Z", null, "2016-01-14T18:25:10Z", null, 0, 0, "09000064805c9af7"], ["FDA-2000-P-0924-0002", "FDA", "FDA-2000-P-0924", "Final Rule- Cardiovascular Devices: Reclassification of Certain Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters", "Rule", "NFR-Notice of Final Rule", "2010-09-08T04:00:00Z", 2010, 9, "2010-09-08T04:00:00Z", null, "2024-08-08T16:30:24Z", "2010-22304", 0, 0, "0900006480b48181"], ["FDA-2010-N-0002-0062", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Ophthalmic Solution; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-09-08T04:00:00Z", 2010, 9, "2010-09-08T04:00:00Z", null, "2010-09-09T15:50:59Z", "2010-22276", 0, 0, "0900006480b48200"], ["FDA-2010-N-0002-0061", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Tiamulin", "Rule", "NFR-Notice of Final Rule", "2010-09-08T04:00:00Z", 2010, 9, "2010-09-08T04:00:00Z", null, "2010-09-09T16:00:35Z", "2010-22277", 0, 0, "0900006480b481aa"], ["FDA-2010-N-0002-0056", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor's Name and Address", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T14:51:56Z", "2010-22044", 0, 0, "0900006480b4490f"], ["FDA-2010-N-0002-0057", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsor: Penicillin G Benzathine and Penicillin G Procaine Suspension; Penicillin G Procaine Aqueous Suspension", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T15:04:07Z", "2010-22042", 0, 0, "0900006480b449d2"], ["FDA-2010-N-0002-0052", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feed: Ractopamine", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T14:36:56Z", "2010-22071", 0, 0, "0900006480b444d4"], ["FDA-2010-N-0002-0054", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Florfenicol and Flunixin", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, null, null, "2010-09-03T14:45:33Z", "2010-22039", 0, 0, "0900006480b444ef"], ["FDA-2010-N-0002-0058", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Praziquantel and Pyrantel", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T15:07:38Z", "2010-22043", 0, 0, "0900006480b449d4"], ["FDA-2010-N-0002-0051", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Changes of Sponsors; Withdrawals of Approvals of New Animal Drug Applications: Deslorelin Acetate; Dichlorophene and Toluene Capsules; Pyrantel Pamoate Suspension", "Rule", "CEP-Certificate Extending Patent Term", "2010-08-27T04:00:00Z", 2010, 8, "2010-08-27T04:00:00Z", null, "2010-08-27T13:34:20Z", "2010-21296", 0, 0, "0900006480b3c459"], ["FDA-1993-N-0150-0002", "FDA", "FDA-1993-N-0150", "Financial Disclosure by Clinical Investigators; Correction", "Rule", "NCR-Notice of Correction", "2010-07-27T04:00:00Z", 2010, 7, "2010-07-27T04:00:00Z", null, "2010-07-27T20:52:38Z", null, 0, 0, "09000064804ff2da"], ["FDA-2009-N-0458-0010", "FDA", "FDA-2009-N-0458", "Medical Devices; Pediatric Uses of Devices; Requirements for Submission of Information, etc.: Withdrawal", "Rule", "NWL-Notice of Withdrawl", "2010-07-20T04:00:00Z", 2010, 7, null, null, "2011-06-11T16:28:04Z", "2010-17617", 0, 0, "0900006480b1cf7d"], ["FDA-1990-F-0131-0002", "FDA", "FDA-1990-F-0131", "Food Additives Permitted in Feed and Drinking Water of Animals; Formaldehyde; Final Rule", "Rule", "NFR-Notice of Final Rule", "2010-07-06T04:00:00Z", 2010, 7, "2010-07-06T04:00:00Z", "1996-05-10T03:59:59Z", "2010-09-21T01:16:03Z", null, 0, 0, "090000648052cfa0"], ["FDA-2010-N-0002-0048", "FDA", "FDA-2010-N-0002", "Implantations or Injectable Dosages Form New Animal Drugs: Propofol", "Rule", "NFR-Notice of Final Rule", "2010-07-06T04:00:00Z", 2010, 7, null, null, "2010-07-06T15:44:47Z", "2010-16301", 0, 0, "0900006480b13970"], ["FDA-2010-N-0010-0005", "FDA", "FDA-2010-N-0010", "Change of Address; Abbreviated New Drug Applications; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-06-29T04:00:00Z", 2010, 6, null, null, "2010-06-29T13:41:29Z", "2010-15711", 0, 0, "0900006480b0c81f"], ["FDA-2008-C-0098-0006", "FDA", "FDA-2008-C-0098", "Listing of Color Additives Exempt from Certification: Bismuth Citrate; Confirmation of Effective Date", "Rule", "NCD-Notice of Confirmation of Effective Date", "2010-06-17T04:00:00Z", 2010, 6, null, null, "2010-10-29T01:09:59Z", "2010-14598", 0, 0, "0900006480b03b70"], ["FDA-2010-N-0002-0045", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Florfenicol", "Rule", "NFR-Notice of Final Rule", "2010-06-17T04:00:00Z", 2010, 6, null, null, "2010-10-29T01:10:45Z", "2010-14611", 0, 0, "0900006480b03b6f"], ["FDA-2008-N-0163-0294", "FDA", "FDA-2008-N-0163", "Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury, Designation of Special Controls for Dental Amalgam, Mercury, and Amalgam Alloy; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-06-11T04:00:00Z", 2010, 6, null, null, "2011-06-11T16:27:42Z", "2010-14083", 0, 0, "0900006480b002a6"], ["FDA-2010-N-0010-0004", "FDA", "FDA-2010-N-0010", "Change of Contact Information; Technical Amendment", "Rule", "N-Notice", "2010-06-09T04:00:00Z", 2010, 6, "2010-06-09T04:00:00Z", null, "2010-06-09T16:29:08Z", "2010-13820", 0, 0, "0900006480afeb5e"], ["FDA-2010-N-0002-0041", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution", "Rule", "NFR-Notice of Final Rule", "2010-05-12T04:00:00Z", 2010, 5, "2010-05-12T04:00:00Z", null, "2010-05-12T13:53:44Z", "2010-11244", 0, 0, "0900006480aebea3"], ["FDA-2010-N-0002-0039", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin", "Rule", "NFR-Notice of Final Rule", "2010-05-12T04:00:00Z", 2010, 5, "2010-05-12T04:00:00Z", null, "2010-05-12T13:37:48Z", "2010-11282", 0, 0, "0900006480aebe42"], ["FDA-2010-N-0002-0043", "FDA", "FDA-2010-N-0002", "Oral Dosages Form New Animal Drugs: Orbifloxacin Suspension", "Rule", "NFR-Notice of Final Rule", "2010-05-12T04:00:00Z", 2010, 5, "2010-05-12T04:00:00Z", null, "2010-05-12T14:14:28Z", "2010-11245", 0, 0, "0900006480aebeee"], ["FDA-2010-N-0002-0038", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products: Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos", "Rule", "NFR-Notice of Final Rule", "2010-05-05T04:00:00Z", 2010, 5, "2010-05-05T04:00:00Z", null, "2010-05-05T18:21:18Z", "2010-10564", 0, 0, "0900006480ae7219"], ["FDA-1992-N-0132-0001", "FDA", "FDA-1992-N-0132", "Food and Color Additives; Generally Recognized As Safe Substances; Technical Amendments", "Rule", "Final Rule", "2010-04-30T04:00:00Z", 2010, 4, "2010-04-30T04:00:00Z", null, "2023-09-20T12:50:19Z", "92-7106", 0, 0, "090000648052dbd3"], ["FDA-1986-F-0378-0002", "FDA", "FDA-1986-F-0378", "Irradiation In The Production, Processing, and Handling of Foods", "Rule", "Final Rule", "2010-04-30T04:00:00Z", 2010, 4, "2010-04-30T04:00:00Z", "1989-03-24T04:59:59Z", "2023-02-10T17:02:33Z", "89-3864", 0, 0, "09000064805110a0"], ["FDA-2010-N-0002-0035", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Butorphanol", "Rule", "NFR-Notice of Final Rule", "2010-04-29T04:00:00Z", 2010, 4, null, null, "2010-04-29T14:05:53Z", "2010-09871", 0, 0, "0900006480ae39a6"], ["FDA-2010-N-0002-0032", "FDA", "FDA-2010-N-0002", "Certain Other Dosage Form New Animal Drugs; Detomidine", "Rule", "NFR-Notice of Final Rule", "2010-04-23T04:00:00Z", 2010, 4, null, null, "2010-04-23T15:05:24Z", "2010-09371", 0, 0, "0900006480ade6c3"], ["FDA-2010-N-0010-0003", "FDA", "FDA-2010-N-0010", "Center for Devices and Radiological Health; New Address Information", "Rule", "NFR-Notice of Final Rule", "2010-04-22T04:00:00Z", 2010, 4, null, null, "2010-04-22T14:01:49Z", "2010-08863", 0, 0, "0900006480adcfd6"], ["FDA-2010-N-0002-0030", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Melengestrol, Monensin, and Ractopamine", "Rule", "NFR-Notice of Final Rule", "2010-04-22T04:00:00Z", 2010, 4, null, null, "2010-04-22T13:40:34Z", "2010-09304", 0, 0, "0900006480adcfba"], ["FDA-2010-N-0002-0028", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2010-04-20T04:00:00Z", 2010, 4, "2010-04-20T04:00:00Z", null, "2024-11-12T04:53:46Z", "2010-09057", 1, 0, "0900006480adba4f"], ["FDA-2010-N-0002-0029", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2010-04-20T04:00:00Z", 2010, 4, "2010-04-20T04:00:00Z", null, "2024-11-12T04:53:58Z", "2010-09045", 1, 0, "0900006480adbad7"], ["FDA-2010-N-0002-0027", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Change of Sponsor; Propofol", "Rule", "NFR-Notice of Final Rule", "2010-04-19T04:00:00Z", 2010, 4, "2010-04-19T04:00:00Z", null, "2024-11-07T22:17:54Z", "2010-08945", 1, 0, "0900006480adaf52"], ["FDA-2006-N-0304-0039", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designation: Flunisolide, etc.", "Rule", "NFR-Notice of Final Rule", "2010-04-14T04:00:00Z", 2010, 4, "2010-04-14T04:00:00Z", null, "2011-06-11T16:25:59Z", "2010-08467", 0, 0, "0900006480ad7218"], ["FDA-2000-N-0190-0110", "FDA", "FDA-2000-N-0190", "Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation, etc.; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-04-13T04:00:00Z", 2010, 4, null, null, "2010-04-13T14:28:09Z", "2010-08358", 0, 0, "0900006480ad65c5"], ["FDA-1975-N-0017-0050", "FDA", "FDA-1975-N-0017", "See FDA-1975-N-0017-0028", "Rule", "NFR-Notice of Final Rule", "2010-04-09T04:00:00Z", 2010, 4, "2010-04-09T04:00:00Z", null, "2011-02-08T14:46:37Z", null, 0, 0, "0900006480ad3b5e"], ["FDA-1999-N-3539-0001", "FDA", "FDA-1999-N-3539", "Technical Amendments: Administrative Practices and Procedures; Good Guidance Practices", "Rule", "Final Rule", "2010-04-01T04:00:00Z", 2010, 4, null, null, "2015-11-10T15:50:14Z", "2010-07286", 0, 0, "0900006480ace273"], ["FDA-2009-N-0458-0002", "FDA", "FDA-2009-N-0458", "Medical Devices; Pediatric Uses of Devices: Requirement for Submission of Information on Pediatric Subpopulations That Suffer From a Disease, et al.", "Rule", "NFR-Notice of Final Rule", "2010-04-01T04:00:00Z", 2010, 4, "2010-04-01T04:00:00Z", "2010-06-16T03:59:59Z", "2011-06-11T16:28:04Z", "2010-07193", 0, 0, "0900006480ace1bb"], ["FDA-2010-N-0010-0002", "FDA", "FDA-2010-N-0010", "Technical Amendments: Medical Devices", "Rule", "NFR-Notice of Final Rule", "2010-04-01T04:00:00Z", 2010, 4, null, null, "2010-04-01T15:59:32Z", "2010-07288", 0, 0, "0900006480ace17c"], ["FDA-2010-N-0002-0025", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs: Orbifloxacin, Mometasone Furoate Monohydrate, and Posaconazole Suspension", "Rule", "NFR-Notice of Final Rule", "2010-04-01T04:00:00Z", 2010, 4, null, null, "2010-04-01T16:05:18Z", "2010-07163", 0, 0, "0900006480ace19b"], ["FDA-2010-N-0148-0001", "FDA", "FDA-2010-N-0148", "Revision of Organization and Conforming Changes to Regulations", "Rule", "NFR-Notice of Final Rule", "2010-04-01T04:00:00Z", 2010, 4, null, null, "2010-04-01T15:54:52Z", "2010-07282", 0, 0, "0900006480ace164"], ["FDA-2003-N-0446-0027", "FDA", "FDA-2003-N-0446", "New Animal Drugs: Removal of Obsolete and Redundant Regulations", "Rule", "NFR-Notice of Final Rule", "2010-03-31T04:00:00Z", 2010, 3, "2010-03-31T04:00:00Z", null, "2010-03-31T18:16:34Z", "2010-07108", 0, 0, "0900006480acd296"], ["FDA-2003-N-0446-0026", "FDA", "FDA-2003-N-0446", "New Animal Drugs for Use in Animal Feeds; CFR Correction", "Rule", "CFR-Correction", "2010-03-30T04:00:00Z", 2010, 3, "2010-03-30T04:00:00Z", null, "2010-03-31T18:32:57Z", "2010-07095", 0, 0, "0900006480acc25e"], ["FDA-2010-N-0001-0032", "FDA", "FDA-2010-N-0001", "Advisory Committees; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-03-29T04:00:00Z", 2010, 3, null, null, "2010-03-29T14:47:46Z", "2010-06861", 0, 0, "0900006480aca86c"], ["FDA-2008-C-0098-0003", "FDA", "FDA-2008-C-0098", "Listing of Color Additives Exempt From Certification: Bismuth Citrate", "Rule", "NFR-Notice of Final Rule", "2010-03-26T04:00:00Z", 2010, 3, "2010-04-26T04:00:00Z", null, "2010-04-22T16:10:20Z", "2010-06731", 0, 0, "0900006480ac9372"], ["FDA-1993-N-0259-0016", "FDA", "FDA-1993-N-0259", "Beverages; Bottled Water", "Rule", "Final Rule", "2010-03-24T04:00:00Z", 2010, 3, "2010-03-24T04:00:00Z", null, "2024-04-12T12:24:50Z", "96-6940", 0, 0, "0900006480503ebc"], ["FDA-2010-N-0010-0001", "FDA", "FDA-2010-N-0010", "Product Jurisdiction: Change of Address and Telephone Number; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-03-23T04:00:00Z", 2010, 3, "2010-03-23T04:00:00Z", null, "2010-03-23T15:23:04Z", "2010-06246", 0, 0, "0900006480ac615b"], ["FDA-2010-N-0002-0023", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Flunixin", "Rule", "NFR-Notice of Final Rule", "2010-03-19T04:00:00Z", 2010, 3, null, null, "2010-03-19T14:36:48Z", "2010-06038", 0, 0, "0900006480ac18f4"], ["FDA-1995-N-0259-0002", "FDA", "FDA-1995-N-0259", "Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco To Protect Children and Adolescents", "Rule", "NFR-Notice of Final Rule", "2010-03-19T04:00:00Z", 2010, 3, null, null, "2011-06-11T16:25:43Z", "2010-06087", 0, 0, "0900006480ac184d"], ["FDA-2010-N-0002-0022", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Tetracycline Powder; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-03-18T04:00:00Z", 2010, 3, "2010-03-18T04:00:00Z", null, "2010-03-18T15:23:20Z", "2010-05925", 0, 0, "0900006480ac0362"], ["FDA-2010-N-0002-0016", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Zilpaterol", "Rule", "NFR-Notice of Final Rule", "2010-03-11T05:00:00Z", 2010, 3, null, null, "2010-03-11T15:33:43Z", "2010-05224", 0, 0, "0900006480abaf98"], ["FDA-2009-N-0436-0003", "FDA", "FDA-2009-N-0436", "Confirmation of Effective Date: New Animal Drug Applications", "Rule", "NCD-Notice of Confirmation of Effective Date", "2010-03-08T05:00:00Z", 2010, 3, "2010-03-08T05:00:00Z", null, "2010-03-08T20:12:22Z", "2010-04923", 0, 0, "0900006480ab81f2"], ["FDA-2010-N-0002-0014", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2010-03-05T05:00:00Z", 2010, 3, null, null, "2010-03-09T14:28:56Z", "2010-04560", 0, 0, "0900006480ab5f5b"], ["FDA-1992-N-0049-0028", "FDA", "FDA-1992-N-0049", "Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule", "Rule", "NFR-Notice of Final Rule", "2010-03-04T05:00:00Z", 2010, 3, "2010-03-04T05:00:00Z", null, "2010-03-08T06:09:32Z", null, 0, 0, "0900006480ab4f84"], ["FDA-1981-N-0114-0001", "FDA", "FDA-1981-N-0114", "Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule", "Rule", "NFR-Notice of Final Rule", "2010-03-04T05:00:00Z", 2010, 3, null, null, "2011-06-11T16:25:43Z", "2010-04424", 0, 0, "0900006480ab4db0"], ["FDA-2010-N-0002-0009", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Bacitracin Zinc; Nicarbazin", "Rule", "NFR-Notice of Final Rule", "2010-02-22T05:00:00Z", 2010, 2, "2010-02-22T05:00:00Z", null, "2010-02-23T13:57:08Z", "2010-03328", 0, 0, "0900006480aa9b3b"], ["FDA-2009-N-0665-0085", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor - Final Rule", "Rule", "Final Rule", "2010-01-20T05:00:00Z", 2010, 1, "2010-01-20T05:00:00Z", null, "2014-01-07T21:41:55Z", "2010-00930", 0, 0, "0900006480a802fb"], ["FDA-2009-N-0665-0083", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol and Flunixin", "Rule", "Final Rule", "2010-01-11T05:00:00Z", 2010, 1, null, null, "2014-07-11T16:33:22Z", "2010-00209", 0, 0, "0900006480a7b385"], ["FDA-2009-N-0665-0080", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium - Final Rule", "Rule", "Final Rule", "2010-01-11T05:00:00Z", 2010, 1, null, null, "2014-01-07T21:41:03Z", "2010-00207", 0, 0, "0900006480a7b29f"], ["FDA-2009-N-0665-0081", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Ractopamine - Final Rule", "Rule", "Final Rule", "2010-01-11T05:00:00Z", 2010, 1, null, null, "2014-01-07T21:43:54Z", "2010-00208", 0, 0, "0900006480a7b2e7"]], "truncated": false, "filtered_table_rows_count": 87, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Rule", "p2": "2010"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010", "results": [{"value": "FDA", "label": "FDA", "count": 87, "toggle_url": "https://pawtectors.org/openregs/documents.json?document_type=Rule&posted_year=2010", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010", "results": [{"value": "Rule", "label": "Rule", "count": 87, "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2010", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010", "results": [{"value": 2010, "label": 2010, "count": 87, "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet=posted_month"}, {"name": "comment_end_date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Rule&posted_year=2010&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 386.00467098876834, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}